MSD and partner Moderna have started a late-stage trial of their personalised cancer vaccine V940 as a combination with MSD’s PD-1 inhibitor Keytruda for patients with non-small cell lung cancer ...

MSD's cancer immunotherapy Keytruda will soon be available as a subcutaneous injection that does away with the need to visit an infusion clinic. Keytruda Qlex (pembrolizumab and berahyaluronidase alfa ...

While the CVT is enjoying a bit of a purple patch right now with many car-makers using it for its efficiency benefits, you’re not the only one, Gregg, that doesn’t want to own such a thing. The CVT’s ...